| NCT ID | NCT07257835 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Fudan University |
| Condition | Eosinophilic Gastrointestinal Disorders (EGIDs) |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2025-01-01 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a single-center observational study to investigate the efficacy and tolerability of dupilumab in children with refractory eosinophilic gastrointestinal disorders.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of Refractory Peptic Ulcers * with Refractory Eosinophilic Gastrointestinal Disorders Exclusion Criteria: * with Active Helicobacter pylori infection at present. * with Inflammatory bowel disease * with Parasite infection * with Cancer
Frequently Asked Questions
Who can join the NCT07257835 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 18 Years, studying Eosinophilic Gastrointestinal Disorders (EGIDs). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07257835 currently recruiting?
Yes, NCT07257835 is actively recruiting participants. Visit ClinicalTrials.gov or contact Children's Hospital of Fudan University to inquire about joining.
Where is the NCT07257835 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT07257835 clinical trial?
NCT07257835 is sponsored by Children's Hospital of Fudan University. The trial plans to enroll 20 participants.